236 related articles for article (PubMed ID: 21969805)
1. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach.
Kedia N
Diabetes Metab Syndr Obes; 2011; 4():337-46. PubMed ID: 21969805
[TBL] [Abstract][Full Text] [Related]
2. Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized.
Pearson T
Diabetes Educ; 2008; 34(1):128-34. PubMed ID: 18267999
[TBL] [Abstract][Full Text] [Related]
3. Glucagon: Its evolving role in the management of hypoglycemia.
Isaacs D; Clements J; Turco N; Hartman R
Pharmacotherapy; 2021 Jul; 41(7):623-633. PubMed ID: 33963599
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemia and Glucagon Utilization in Insulin-Treated Diabetic Patients.
Vilovic M; Kurir TT; Novak A; Krnic M; Borovac JA; Lizatovic IK; Kokic V; Bozic J
Exp Clin Endocrinol Diabetes; 2020 Aug; 128(8):493-498. PubMed ID: 30428496
[TBL] [Abstract][Full Text] [Related]
5. Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study.
Yale JF; Dulude H; Egeth M; Piché CA; Lafontaine M; Carballo D; Margolies R; Dissinger E; Shames AR; Kaplowitz N; Zhang MX; Zhang S; Guzman CB
Diabetes Technol Ther; 2017 Jul; 19(7):423-432. PubMed ID: 28556672
[TBL] [Abstract][Full Text] [Related]
6. Perceptions About Glucagon Delivery Devices for Severe Hypoglycemia: Qualitative Research With Patients, Caregivers, and Acquaintances.
Bajpai SK; Cambron-Mellott MJ; Peck E; Poon JL; Wang Q; Mitchell BD; Babrowicz J; Child CJ; Raibulet NK; Beusterien K
Clin Ther; 2019 Oct; 41(10):2073-2089.e6. PubMed ID: 31526655
[TBL] [Abstract][Full Text] [Related]
7. Newly Approved Novel Dosage Forms of Glucagon for Management of Severe Hypoglycemia.
Borden TJ; Baker DE; Levien TL; Gates BJ
Sr Care Pharm; 2020 Apr; 35(4):176-181. PubMed ID: 32192567
[TBL] [Abstract][Full Text] [Related]
8. NASAL GLUCAGON DELIVERY IS MORE SUCCESSFUL THAN INJECTABLE DELIVERY: A SIMULATED SEVERE HYPOGLYCEMIA RESCUE.
Settles JA; Gerety GF; Spaepen E; Suico JG; Child CJ
Endocr Pract; 2020 Apr; 26(4):407-415. PubMed ID: 32293921
[No Abstract] [Full Text] [Related]
9. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
Katsura M
Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1276-88. PubMed ID: 3542595
[TBL] [Abstract][Full Text] [Related]
10. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.
Lorenzi M; Bohannon N; Tsalikian E; Karam JH
West J Med; 1984 Oct; 141(4):467-71. PubMed ID: 6390972
[TBL] [Abstract][Full Text] [Related]
11. Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional Study.
Kelly CS; Nguyen H; Luo W; Chapman K; Poon JL; Perez-Nieves M; Baker L; Wolf WA; Mitchell B
Diabetes Ther; 2023 Aug; 14(8):1285-1298. PubMed ID: 37268778
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
13. A brief interactive training with medical students improves their diabetes knowledge about hypoglycemia.
Beverly EA; Ritholz MD; Rennie RG; Mort SC
BMC Med Educ; 2019 May; 19(1):171. PubMed ID: 31138204
[TBL] [Abstract][Full Text] [Related]
14. Glucagon underutilized among type 1 diabetes mellitus patients in Japan.
Murata T; Okazaki K; Yanagisawa K; Yamada K; Kuribayashi N; Totsuka Y; Hiyoshi T; Naka M; Sugimoto M; Aoki Y; Waki M; Furuya M; Kitaoka H; Oishi M; Shimizu I; Miyaoka H; Yamamoto T; Yamada K; Sakane N
Diabetes Technol Ther; 2013 Sep; 15(9):748-50. PubMed ID: 23758283
[TBL] [Abstract][Full Text] [Related]
15. Assessing Parental Competence and Self-Ratings in Management of Pediatric Type 1 Diabetes and Emergency Glucagon Administration-An Exploratory Observational Study.
Eisenhofer S; Neininger MP; Bertsche A; Kiess W; Bertsche T; Kapellen TM
Children (Basel); 2023 Jul; 10(8):. PubMed ID: 37628318
[TBL] [Abstract][Full Text] [Related]
16. [Tight glycemic control in the management of diabetic patients: what has changed since the '90s in the clinical approach?].
Fiorentino TV; Sesti G
G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):13S-20S. PubMed ID: 25623546
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients With Diabetes: A Systematic Review.
Singh-Franco D; Moreau C; Levin AD; Rosa D; Johnson M
Clin Ther; 2020 Sep; 42(9):e177-e208. PubMed ID: 32873417
[TBL] [Abstract][Full Text] [Related]
18. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
Deeb LC; Dulude H; Guzman CB; Zhang S; Reiner BJ; Piché CA; Pradhan S; Zhang XM
Pediatr Diabetes; 2018 Aug; 19(5):1007-1013. PubMed ID: 29512902
[TBL] [Abstract][Full Text] [Related]
19. Role of Glucagon in Automated Insulin Delivery.
Wilson LM; Jacobs PG; Castle JR
Endocrinol Metab Clin North Am; 2020 Mar; 49(1):179-202. PubMed ID: 31980117
[TBL] [Abstract][Full Text] [Related]
20. Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies.
Lowe RN; Trujillo JM
Ann Pharmacother; 2020 Aug; 54(8):780-787. PubMed ID: 32052651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
